Bankoglu EE, Tschopp O, Schmitt J, et al. (2016) Role of PTEN in Oxidative Stress and DNA Damage in the Liver of Whole-Body Pten Haplodeficient Mice. PLoS One 11:e0166956
Ceni E, Mello T, Galli A (2014) Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World Journal of Gastroenterology 20:17756–17772
Cheng C, Pan T-M (2011) Protective effect of Monascus-fermented red mold rice against alcoholic liver disease by attenuating oxidative stress and inflammatory response. Journal of Agricultural and Food Chemistry 59:9950–9957
Dey A, Cederbaum AI (2006) Alcohol and Oxidative Liver Injury. Hepatology 43:S63-S74
Gustot T, Jalan R (2019) Acute-on-chronic liver failure in patients with alcohol-related liver disease. Journal of Hepatology 70:319–327
Lieber CS (2004) Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34:9–19
Liu H, Li X-M, Liu Y, Zhang P, Wang J-N, Wang B-G (2016) Chermesins A-D: meroterpenoids with a drimane-type spirosesquiterpene skeleton from the marine algal-derived endophytic fungus Penicillium chermesinum EN-480. Journal of Natural Products 79:806–811
Liu K, Wang F-U, Xu R (2021) Neutrophils in liver diseases: pathogenesis and therapeutic targets. Cellular & Molecular Immunology 18:38–44
Nicoletti R, Trincone A (2016) Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin. Marine Drugs 14:37
Pandit SG, Mekala K-PR, Puttananjaiah MH, Dhale MA (2019) Cicer arietinum (Bengal gram) husk as alternative for Talaromyces purpureogenus CFRM02 pigment production: Bioactivities and identification. LWT:108499
Pandit SG, Puttananjaiah MH, Harohally NV, Dhale MA (2018) Functional attributes of a new molecule-2-hydroxymethyl-benzoic acid 2′-hydroxy-tetradecyl ester isolated from Talaromyces purpureogenus CFRM02. Food Chemistry 255:89–96
Pandit SG, Puttananjaiah MH, Peddha MS, Dhale MA (2020) Safety efficacy and chemical profiling of water-soluble Talaromyces purpureogenus CFRM02 pigment. Food Chemistry:125869
Rosato V, Abenavoli L, Federico A, Masarone M, Persico M (2016) Pharmacotherapy of alcoholic liver disease in clinical practice. The Intenational Journal of Clinical Practice 70:119–131
Sarin SK, Pande A, Schnabl B (2019) Microbiome as a therapeutic target in alcohol-related liver disease. Journal of Hepatology 70:260–272
Seth D, Haber PS, Syn W-K, Diehl AM, Day CP (2011) Pathogenesis of alcohol-induced liver disease: Classical concepts and recent advances. Journal of Gastroenterology and Hepatology 26:1089–1105
Shi X, DeLucia AL, Bao J, Zhang P (2019) Alcohol abuse and disorder of granulopoiesis. Pharmacology & Therapeutics 198:206–219
Singal AK, Kodali S, Vucovich LA, Darley-Usmar V, Schiano TD (2016) Diagnosis and treatment of alcoholic hepatitis: a systematic review. Alcoholism: Clinical and Experimental Research 40:1390–1402
Singal AK, Shah VH (2019) Current trials and novel therapeutic targets for alcoholic hepatitis. Journal of Hepatology 70:305–313
Tan HK, Yates H, Lilly K, Dhanda AD (2020) Oxidative stress in alcohol-related liver disease. World Journal of Hepatology 27:332–349
Tang J, Yan Z, Feng Q, Yu L, Wang H (2021) The Roles of Neutrophils in the Pathogenesis of Liver Diseases. Frontiers in Immunology 12:625472
Vuittonet CL, Halse M, Leggio L, et al. (2014) Pharmacotherapy for alcoholic patients with alcoholic liver disease. American Journal of Health-System Pharmacy 71:1265–1276